Please ensure Javascript is enabled for purposes of website accessibility
Russia Publishes Virus Vaccine Results, Weeks After Approval
gvw_ap_news
By Associated Press
Published 5 years ago on
September 4, 2020

Share

MOSCOW — Russian scientists have belatedly published first results from early trials into the experimental Sputnik V vaccine, which received government approval last month but drew considerable criticism from experts, as the shots had only been tested on several dozen people before being more widely administered.

In a report published in the journal Lancet on Friday, developers of the vaccine said it appeared to be safe and to prompt an antibody response in all 40 people tested in the second phase of the study within three weeks. However, the authors noted that participants were only followed for 42 days, the study sample was small and there was no placebo or control vaccine used.

One part of the safety trial included only men and the study mostly involved people in their 20s and 30s, so it is unclear how the vaccine might work in older populations most at risk of the more severe complications of COVID-19.

International experts remained cautious over the vaccine’s effectiveness and safety. Nevertheless, its Russian developers made some bold claims Friday after presenting the findings to reporters.

Professor Alexander Gintsburg, director of the Moscow-based Gamaleya Institute that developed the vaccine with assistance from Russia’s Defense Ministry, told reporters that the vaccine triggers “sufficient” immune response “to counteract any imaginable dose infecting (a person) with COVID-19.”

One Part of the Study Involved a Frozen Formulation of the Vaccine

“We are ready to assert that the protective effect of this vaccine will be detectable and remain at a proper level for 2 years, or maybe even more,” Gintsburg said, without providing any evidence to back up the claim.

According to the Lancet report, the trials took place in two Russian hospitals involving healthy adults aged 18 to 60, who were required to self-isolate once they registered for the trial. They remained in the hospital for the first 28 days of the study after being vaccinated.

One part of the study involved a frozen formulation of the vaccine while another studied a freeze-dried variation. Scientists said the frozen vaccine would be suitable for current global vaccine supply chains while the freeze-dried version could be used in hard-to-reach areas.

Both vaccines used a modified version of the common cold-causing adenovirus to carry genes for the spike protein in the coronavirus, as a way to prime the body to react if a real virus causing COVID-19 comes along. That’s a similar technology to the vaccines being developed by China’s CanSino Biologics and Britain’s Oxford University and AstraZeneca.

Russian researchers said all 40 participants produced a neutralizing antibody response, molecules which are key to blocking infection. The vaccines also appeared to trigger a reaction in the body’s T-Cells, which help by destroying cells that have been invaded by the virus.

The most commonly reported side effects were pain at the injection site, fever, headache, and muscle or joint pain.

In this handout photo taken on Thursday, Aug. 6, 2020, and provided by Russian Direct Investment Fund, a new vaccine is on display at the Nikolai Gamaleya National Center of Epidemiology and Microbiology in Moscow, Russia. Russia on Tuesday, Aug. 11 became the first country to approve a coronavirus vaccine for use in tens of thousands of its citizens despite international skepticism about injections that have not completed clinical trials and were studied in only dozens of people for less than two months. (Alexander Zemlianichenko Jr/ Russian Direct Investment Fund via AP)

The Vaccine Was Approved by the Russian Government With Much Fanfare

In an accompanying commentary, Dr. Naor Bar-Zeev of the Johns Hopkins Bloomberg School of Public Health and colleagues wrote that the studies were “encouraging but small.” They said that the immune reaction elicited by the vaccine “bodes well” but that “efficacy for any COVID-19 vaccine has not yet been shown.”

Bar-Zeev and colleagues said that proving the safety of any coronavirus vaccine would be critical.

“Since vaccines are given to healthy people and during the COVID-19 pandemic, potentially to everyone after approval following (advanced) trials, safety is paramount,” the scientists wrote.

Dr. Ohid Yaqub, senior lecturer at the Science Policy Research Unit at the University of Sussex, said the limited study size was not enough for regulatory approval, which the vaccine received last month.

“The design and size of (an early) study is not anywhere near sufficient for widely recognized standards of approval. The study was not randomized, and it was not large enough to detect rarer safety issues,” Yaqub said.

The vaccine was approved by the Russian government with much fanfare on Aug. 11. President Vladimir Putin personally broke the news on national television and said that one of his daughters had already been vaccinated, experienced slight side effects and developed antibodies. Since then, several high-profile officials also said they had taken the shots, including Moscow Mayor Sergei Sobyanin and Defense Minister Sergei Shoigu.

It remains unclear whether they were among the volunteers in clinical trials or accessed the vaccine in some other way.

Numerous Public Health Experts Expressed Concern Last Month

Russian health authorities announced advanced trials of the vaccine among 40,000 volunteers last month. According to official records, it will be a randomized, double-blind, placebo-controlled study. Officials also mentioned that vaccination of risk groups, such as doctors and teachers, may be carried out “in parallel” — but it remains unclear whether it will be done as part of the study.

Michael Head, a senior research fellow in global health at Britain’s University of Southampton, agreed the Russian vaccine appeared to be “promising,” but that further studies were needed.

“At this stage, we do not actually know if the vaccine works,” he said. Head was not linked to the Russian research. “Public confidence in any vaccine is vital,” he said in a statement, calling suggestions from Russian and other authorities that a vaccine could be fast-tracked without the proper research “problematic.”

“Ultimately, we must not pour additional fuel on the anti-vaccine lobby fires,” he said.

Numerous public health experts expressed concern last month that Russia had approved the Sputnik V vaccine before publishing any data.

The World Health Organization said last month it had started discussions with Russia to obtain more details about their candidate vaccine. But on Friday, WHO spokeswoman Dr. Margaret Harris said she “had no specific information on Russia … and who is sharing what (data) with who.” She said the agency’s aim was “to get all countries together and get all the information.”

RELATED TOPICS:

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Life-Threatening Meals: Restaurants Would Identify Food Allergens for Diners Under This Proposed Law

DON'T MISS

Iran Threatens to Strike US Bases in Region if Military Conflict Arises

DON'T MISS

Trump Has Cut Science Funding to Its Lowest Level in Decades

DON'T MISS

Fresno Measure C Transportation Tax Talks Continue Amid Renewal Uncertainty

DON'T MISS

Judge Bars Trump Administration From Detaining Mahmoud Khalil

DON'T MISS

Is a Waxed Apple ‘Ultra-Processed?’ CA Bill Could Trigger a Lawsuit Barrage

DON'T MISS

Edmunds: These Five Vehicles Are Hidden Automotive Gems

DON'T MISS

GM to Invest $4 Billion to Shift Some Production From Mexico to the US

DON'T MISS

How Your Air Conditioner Can Help the Power Grid, Rather Than Overloading It

DON'T MISS

Hundreds of Laid-off CDC Employees Are Being Reinstated

UP NEXT

Israel Strikes Hodeidah Port, Threatens Naval, Air Blockade

UP NEXT

Trump Warns Protests at Army Parade Will Be Met With Force

UP NEXT

Britain and Allies Sanction Israeli Far-Right Ministers for ‘Inciting Violence’

UP NEXT

Trump Aide Criticizes Mexican President on Los Angeles Protests

UP NEXT

Do Americans Support Trump’s Use of Marines in LA? The Numbers Might Shock You

UP NEXT

Israeli Gunfire Kills 17 People Near Gaza Aid Site, Health Officials Say

UP NEXT

Parliament Member Corbyn Calls for Inquiry Into UK Role in Gaza War

UP NEXT

Turkey Condemns Interception of Gaza-Bound Aid Ship, Calls Israel a ‘Terror State’

UP NEXT

US Military Evaluating Options to Prevent Nuclear-Armed Iran, General Says

UP NEXT

Israeli Military Says Missile Launched From Yemen Toward Israel, Seeking to Intercept It

Tulare County Inmate Found Unresponsive in Cell, Autopsy Pending

41 minutes ago

A Look at Boeing’s Recent Troubles After Air India Crash

42 minutes ago

Gavin Newsom Changes His Tune on Running for President

43 minutes ago

McConnell, Mathurin Lead Pacers’ Bench Charge in Game 3, Fueling 2-1 NBA Finals Lead Over Thunder

47 minutes ago

US Sen. Alex Padilla Was Forcibly Removed After Interrupting News Conference by Homeland Security Secretary Kristi Noem

49 minutes ago

Fresno Joins Nationwide ‘No Kings Day’ Movement at Multiple Locations

50 minutes ago

JetBlue Flight Rolls off Runway at Boston Airport, No Injuries Reported

54 minutes ago

Teoscar Hernández Hits a 3-Run Homer and the Dodgers Beat the Padres to Win the Series

1 hour ago

Giants Rally Again to Beat Lowly Rockies for 7th Straight Win

1 hour ago

Wildfire Burns in Madera County With No Containment

1 hour ago

An Anti-War Movement Is Stirring in Israel

I just spent a week in Israel and, while it may not look as if much has changed — the grinding war in the Gaza Strip continues to grind — I ...

10 minutes ago

10 minutes ago

An Anti-War Movement Is Stirring in Israel

26 minutes ago

David Greenwood, Former UCLA Star and NBA Champion, Dies at 68 After Cancer Battle

36 minutes ago

Is the Trump-Musk Spat Really Over? Judging From Wall Street Trading, It’s a Fragile Peace

Tulare County Sheriff's Office detectives are investigating a shooting in Strathmore that left a man wounded late night on Wednesday, Feb. 26, 2025. (Tulare County SO)
41 minutes ago

Tulare County Inmate Found Unresponsive in Cell, Autopsy Pending

42 minutes ago

A Look at Boeing’s Recent Troubles After Air India Crash

43 minutes ago

Gavin Newsom Changes His Tune on Running for President

47 minutes ago

McConnell, Mathurin Lead Pacers’ Bench Charge in Game 3, Fueling 2-1 NBA Finals Lead Over Thunder

49 minutes ago

US Sen. Alex Padilla Was Forcibly Removed After Interrupting News Conference by Homeland Security Secretary Kristi Noem

Help continue the work that gets you the news that matters most.

Search

Send this to a friend